NASDAQ NMS - GLOBAL MARKET · TBPH

-0.29% · -$0.0500 · Vol 868.6K

Market closed · last close 4:00 PM ET · price as of 18:13:35 ET

Theravance Biopharma Inc

Pharmaceuticals

$16.93

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for TBPH until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology

NO SCORE SNAPSHOT COVERAGE

AI Analysis

Sovereign

Why is TBPH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move TBPH next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Form 4

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 1
Form 4Sovereign
Samaha Eli Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 17
Form 4Sovereign
Farnum Rhonda Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 22
Form 4Sovereign
Miller Aine Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 22
Form 4Sovereign
Grimaud Brett A. Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 22
Form 4Sovereign
Sawaf Aziz Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 22
Form 4Sovereign
Farnum Rhonda Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 22
Form 4Sovereign
Winningham Rick E Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 23
CongressSovereign
George Whitesides sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Apr 23
CongressSovereign
George Whitesides sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Mar 24
CongressSovereign
George Whitesides sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt

Catalyst calendar

Dated receipts for TBPH are being assembled.

About Theravance Biopharma Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2014

Employees

Country

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$17.00

Day high

$17.02

Day low

$16.91

Previous close

$16.98

52W high

$17.02

-0.53% from high

52W low

$16.91

22% of range

Market cap

$880M

P/E

7.68×

EPS

$-0.5600

Shares out

51.8M

Volume

868.6K

VWAP

$16.98

Price history computed in-house

SMA 50 Not reported · Not reported

SMA 200 Not reported · Not reported

52W position 22%

Veridion warehouse edge

Warehouse intelligence for TBPH.

Veridion Score

Not reported

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

TBPH insider activity

Theravance Biopharma Inc

Score

Coverage building

Pressure

Net selling

Filings

Buys / sells

3 / 43

Net value

-$15.6M

Insiders

Named filers

Samaha Eli

Insider

Leadership

Farnum Rhonda

Insider

Leadership

Miller Aine

Insider

Leadership

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$15.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-07-01	2026-07-01	Samaha Eli	Insider	sell	$17.00	37,799	9,174,453	$643K	SEC Form 4
2026-07-01	2026-06-30	Samaha Eli	Insider	sell	$17.13	25,027	9,212,252	$429K	SEC Form 4
2026-07-01	2026-06-29	Samaha Eli	Insider	sell	$17.23	273,871	9,237,279	$4.7M	SEC Form 4
2026-06-17	2026-06-15	Farnum Rhonda	Insider	sell	$16.39	6,657	232,457	$109K	SEC Form 4
2026-06-17	2026-06-15	Farnum Rhonda	Insider	sell	$16.38	3,328	239,114	$55K	SEC Form 4